2/24
04:05 pm
ser
Serina Therapeutics Announces Dosing of First Patient in Phase 1b Registrational Trial of SER-252 for Advanced Parkinson’s Disease
Medium
Report
Serina Therapeutics Announces Dosing of First Patient in Phase 1b Registrational Trial of SER-252 for Advanced Parkinson’s Disease
2/19
06:00 am
ser
Serina Therapeutics Announces First Patient Enrolled in Phase 1b Registrational Trial of SER-252 for Advanced Parkinson's Disease
Low
Report
Serina Therapeutics Announces First Patient Enrolled in Phase 1b Registrational Trial of SER-252 for Advanced Parkinson's Disease
2/3
06:58 am
ser
Registration Is Now Open For Tribe Public's CEO Presentation and Q&A Webinar Event [Yahoo! Finance]
Medium
Report
Registration Is Now Open For Tribe Public's CEO Presentation and Q&A Webinar Event [Yahoo! Finance]
2/3
06:00 am
ser
Registration Is Now Open For Tribe Public’s CEO Presentation and Q&A Webinar Event
Medium
Report
Registration Is Now Open For Tribe Public’s CEO Presentation and Q&A Webinar Event
1/15
04:43 pm
ser
Serina Therapeutics receives NYSE notification [Seeking Alpha]
High
Report
Serina Therapeutics receives NYSE notification [Seeking Alpha]
1/15
04:30 pm
ser
Serina Therapeutics Receives NYSE Deficiency Notification Regarding Shareholders' Equity
High
Report
Serina Therapeutics Receives NYSE Deficiency Notification Regarding Shareholders' Equity
12/11
04:47 pm
ser
Serina Therapeutics Strengthens Leadership Team with Appointment of Dr. Joshua Thomas as VP, Head of Chemistry [Yahoo! Finance]
Low
Report
Serina Therapeutics Strengthens Leadership Team with Appointment of Dr. Joshua Thomas as VP, Head of Chemistry [Yahoo! Finance]
12/11
04:15 pm
ser
Serina Therapeutics Strengthens Leadership Team with Appointment of Dr. Joshua Thomas as VP, Head of Chemistry
Low
Report
Serina Therapeutics Strengthens Leadership Team with Appointment of Dr. Joshua Thomas as VP, Head of Chemistry
2/17
08:36 am
ser
Form 4 Serina Therapeutics, For: Feb 03 Filed by: Moreadith Randall
Medium
Report
Form 4 Serina Therapeutics, For: Feb 03 Filed by: Moreadith Randall
2/17
08:29 am
ser
Form 4 Serina Therapeutics, For: Feb 03 Filed by: Tenjarla Srini
Medium
Report
Form 4 Serina Therapeutics, For: Feb 03 Filed by: Tenjarla Srini
2/17
08:25 am
ser
Form 4 Serina Therapeutics, For: Feb 03 Filed by: GILL SIMBA
Medium
Report
Form 4 Serina Therapeutics, For: Feb 03 Filed by: GILL SIMBA
2/17
08:20 am
ser
Form 4 Serina Therapeutics, For: Feb 03 Filed by: LEDGER STEVEN A
Medium
Report
Form 4 Serina Therapeutics, For: Feb 03 Filed by: LEDGER STEVEN A
2/17
06:12 am
ser
Form EFFECT Serina Therapeutics,
Medium
Report
Form EFFECT Serina Therapeutics,
2/3
12:36 pm
ser
Form 4 Serina Therapeutics, For: Feb 02 Filed by: Moreadith Randall
Low
Report
Form 4 Serina Therapeutics, For: Feb 02 Filed by: Moreadith Randall
1/30
05:19 pm
ser
Form S-3 Serina Therapeutics,
Medium
Report
Form S-3 Serina Therapeutics,
1/29
12:54 pm
ser
Form 4 Serina Therapeutics, For: Jan 28 Filed by: Moreadith Randall
Medium
Report
Form 4 Serina Therapeutics, For: Jan 28 Filed by: Moreadith Randall
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register